INTELLIGENT BIO SOLUTIONS INC. 8-K

What Happened

• Intelligent Bio Solutions, Inc. (INBS) issued a press release on February 5, 2026 announcing preliminary, unaudited revenue results for its fiscal second quarter ended December 31, 2025. The press release is furnished as Exhibit 99.1 to the Form 8-K. The company did not include specific revenue figures in the Form 8-K text itself.

Key Details

• Filing date: February 5, 2026 (Form 8-K reporting Item 2.02).
• Period covered: fiscal quarter ended December 31, 2025 (fiscal Q2).
• Results described as "preliminary" and "unaudited" — subject to adjustment upon completion of regular close and review procedures.
• Press release provided as Exhibit 99.1; the Form 8-K states the release and exhibit are not being incorporated by reference into other filings and are not deemed "filed" for certain securities‑law liability purposes.

Why It Matters

• Revenue and quarterly results give investors an early view of the company’s recent business performance. Because the figures are preliminary and unaudited, they may change when the company releases its complete, audited quarterly or annual filings.
• Retail investors should review the press release (Exhibit 99.1) for the detailed numbers and monitor subsequent filings (e.g., Form 10-Q or earnings release) for finalized, audited results and management commentary.